Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Boer, S.M. de
(-)
≠ Bessette, P.
(-)
= Verhoeven-Adema, K.W.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(4)
+
-
Availability
Open access
(2)
+
-
Metadata Only
(2)
+
-
Creation Date
2018
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Author
Boer, S.M. de
(4)
+
-
Creutzberg, C.L.
(4)
+
-
Nout, R.A.
(4)
+
-
Putter, H.
(4)
+
-
Bosse, T.
(3)
+
-
PORTEC Study Grp
(3)
+
-
Smit, V.T.H.B.M.
(3)
+
-
Wortman, B.G.
(3)
+
-
Carinelli, S.
(2)
+
-
Chowdhury, M.N.
(2)
+
-
Duvillard, P.
(2)
+
-
Fyles, A.
(2)
+
-
Haie-Meder, C.
(2)
+
-
Hollema, H.
(2)
+
-
Jobsen, J.J.
(2)
+
-
Katsaros, D.
(2)
+
-
Lutgens, L.C.H.W.
(2)
+
-
McLachlin, C.M.
(2)
+
-
Mens, J.W.M.
(2)
+
-
Mileshkin, L.
(2)
+
-
Powell, M.E.
(2)
+
-
Pyman, J.
(2)
+
-
Singh, N.
(2)
+
-
Slot, A.
(2)
+
-
Wilson, G.
(2)
+
-
Show more
Language
en
(4)
+
-
Search results
(1 - 4 of 4)
show grid
show list
save search
Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial
